{"brief_title": "Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia", "brief_summary": "The purpose of this trial is to test the safety & tolerability of intramuscular aripiprazole in acutely agitated patients diagnosed with Dementia.", "condition": "Alzheimer's Disease", "intervention_type": "Drug", "intervention_name": "Placebo", "description": "IM Solution, IM, Cohort 1 - 0mg; 2 injections 2nd injection 2 hours after first; Cohort 2 - 0mg; 2 injections 2nd injection 2 hours after first; Cohort 3 - 0mg; 1 injection, 24 hour observation for all cohorts.", "arm_group_label": "B1", "other_name": "Abilify", "criteria": "Inclusion Criteria: - Acute agitation in Patients with a DSM-IV diagnosis of Alzheimer's, vascular or mixed Dementia. Exclusion Criteria: - Current DSM-IV Axis 1 diagnosis other than Alzheimer's, vascular or mixed Dementia.", "gender": "All", "minimum_age": "55 Years", "maximum_age": "95 Years", "healthy_volunteers": "No", "id": "NCT00095719.xml"}